Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Nov;34(11):1241–1244. doi: 10.1136/jcp.34.11.1241

The kidney and liver diseases.

S P Wilkinson
PMCID: PMC494473  PMID: 7320220

Full text

PDF
1241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATKINSON M., LOSOWSKY M. S. The mechanism of ascites formation in chronic liver disease. Q J Med. 1961 Apr;30:153–166. [PubMed] [Google Scholar]
  2. BLOODWORTH J. M., Jr, SOMMERS S. C. "Cirrhotic glomerulosclerosis," a renal lesion associated with hepatic cirrhosis. Lab Invest. 1959 Sep-Oct;8:962–978. [PubMed] [Google Scholar]
  3. Benner E. J., Gourley R. T., Cooper R. A., Jr, Benson J. A., Jr Chronic active hepatitis with lupus nephritis. Ann Intern Med. 1968 Feb;68(2):405–413. doi: 10.7326/0003-4819-68-2-405. [DOI] [PubMed] [Google Scholar]
  4. Berger J., Yaneva H., Nabarra B. Glomerular changes in patients with cirrhosis of the liver. Adv Nephrol Necker Hosp. 1977;7:3–14. [PubMed] [Google Scholar]
  5. Boyer T. D., Zia P., Reynolds T. B. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology. 1979 Aug;77(2):215–222. [PubMed] [Google Scholar]
  6. Callard P., Feldmann G., Prandi D., Belair M. F., Mandet C., Weiss Y., Druet P., Benhamou J. P., Bariety J. Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol. 1975 Aug;80(2):329–340. [PMC free article] [PubMed] [Google Scholar]
  7. Cavanagh D., Rao P. S., Sutton D. M., Bhagat B. D., Bachmann F. Pathophysiology of endotoxin shock in the primate. Am J Obstet Gynecol. 1970 Nov 1;108(5):705–722. doi: 10.1016/0002-9378(70)90535-1. [DOI] [PubMed] [Google Scholar]
  8. Clemente C., Bosch J., Rodés J., Arroyo V., Mas A., Maragall S. Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. Gut. 1977 Jul;18(7):556–560. doi: 10.1136/gut.18.7.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Combes B., Shorey J., Barrera A., Stastny P., Eigenbrodt E. H., Hull A. R., Carter N. W. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 1971 Jul 31;2(7718):234–237. doi: 10.1016/s0140-6736(71)92572-4. [DOI] [PubMed] [Google Scholar]
  10. DAVIS J. O., HOLMAN J. E., CARPENTER C. C., URQUHART J., HIGGINS J. T., Jr AN EXTRA-ADRENAL FACTOR ESSENTIAL FOR CHRONIC RENAL SODIUM RETENTION IN PRESENCE OF INCREASED SODIUM-RETAINING HORMONE. Circ Res. 1964 Jan;14:17–31. doi: 10.1161/01.res.14.1.17. [DOI] [PubMed] [Google Scholar]
  11. EPSTEIN F. H., LESSER G. T., BERGER E. Y. Renal function in decompensated cirrhosis of the liver. Proc Soc Exp Biol Med. 1950 Dec;75(3):822–824. doi: 10.3181/00379727-75-18358. [DOI] [PubMed] [Google Scholar]
  12. Eggert R. C. Spironolactone diuresis in patients with cirrhosis and ascites. Br Med J. 1970 Nov 14;4(5732):401–403. doi: 10.1136/bmj.4.5732.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Epstein M., Berk D. P., Hollenberg N. K., Adams D. F., Chalmers T. C., Abrams H. L., Merrill J. P. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med. 1970 Aug;49(2):175–185. doi: 10.1016/s0002-9343(70)80073-0. [DOI] [PubMed] [Google Scholar]
  14. Epstein M., Levinson R., Sancho J., Haber E., Re R. Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res. 1977 Dec;41(6):818–829. doi: 10.1161/01.res.41.6.818. [DOI] [PubMed] [Google Scholar]
  15. FISHER E. R., HELLSTROM H. R. The membranous and proliferative glomerulonephritis of hepatic cirrhosis. Am J Clin Pathol. 1959 Jul;32(1):48–55. doi: 10.1093/ajcp/32.1.48. [DOI] [PubMed] [Google Scholar]
  16. GARCEAU A. J., CHALMERS T. C. The natural history of cirrhosis. I. Survival with esophageal varices. N Engl J Med. 1963 Feb 28;268:469–473. doi: 10.1056/NEJM196302282680905. [DOI] [PubMed] [Google Scholar]
  17. GILLENWATER J. Y., DOOLEY E. S., FROHLICH E. D. EFFECTS OF ENDOTOXIN ON RENAL FUNCTION AND HEMODYNAMICS. Am J Physiol. 1963 Aug;205:293–297. doi: 10.1152/ajplegacy.1963.205.2.293. [DOI] [PubMed] [Google Scholar]
  18. KERR D. N., WARRICK C. K., HART-MERCER J. A lesion resembling medullary sponge kidney in patients with congenital hepatic fibrosis. Clin Radiol. 1962 Apr;13:85–91. doi: 10.1016/s0009-9260(62)80024-5. [DOI] [PubMed] [Google Scholar]
  19. KUNIN C. M., CHALMERS T. C., LEEVY C. M., SEBASTYEN S. C., LIEBER C. S., FINLAND M. Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease. N Engl J Med. 1960 Feb 25;262:380–385. doi: 10.1056/NEJM196002252620802. [DOI] [PubMed] [Google Scholar]
  20. Klingler E. L., Jr, Vaamonde C. A., Vaamonde L. S., Lancestremere R. G., Morosi H. J., Frisch E., Papper S. Renal function changes in cirrhosis of the liver. A prospective study. Arch Intern Med. 1970 Jun;125(6):1010–1015. [PubMed] [Google Scholar]
  21. Lieberman F. L., Reynolds T. B. Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure. J Clin Invest. 1967 Aug;46(8):1297–1308. doi: 10.1172/JCI105622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lieberman F. L., Reynolds T. B. Renal failure with cirrhosis. Observations on the role of diuretics. Ann Intern Med. 1966 Jun;64(6):1221–1228. doi: 10.7326/0003-4819-64-6-1221. [DOI] [PubMed] [Google Scholar]
  23. Masugi Y., Ishizaki M., Fukuda Y., Sano J., Kogoshi T., Maekawa A., Sugisaki Y. Immunopathologic studies of renal glomerular change in liver cirrhosis with special reference to its pathogenesis. Acta Pathol Jpn. 1979 Jul;29(4):571–583. doi: 10.1111/j.1440-1827.1979.tb00925.x. [DOI] [PubMed] [Google Scholar]
  24. McCloy R. M., Baldus W. P., Tauxe W. N., Summerskill W. H. Plasma volume and renal circulatory function in cirrhosis. Ann Intern Med. 1967 Feb;66(2):307–311. doi: 10.7326/0003-4819-66-2-307. [DOI] [PubMed] [Google Scholar]
  25. Meislin H. W., Lerner S. A., Graves M. H., McGehee M. D., Kocka F. E., Morello J. A., Rosen P. Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med. 1977 Aug;87(2):145–149. doi: 10.7326/0003-4819-87-2-145. [DOI] [PubMed] [Google Scholar]
  26. Nochy D., Callard P., Bellon B., Bariety J., Druet P. Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol. 1976 Oct;6(4):422–427. [PubMed] [Google Scholar]
  27. Oster J. R., Hotchkiss J. L., Carbon M., Vaamonde C. A. Abnormal renal acidification in alcoholic liver disease. J Lab Clin Med. 1975 Jun;85(6):987–1000. [PubMed] [Google Scholar]
  28. Passarge E., McAdams A. J. Cerebro-hepato-renal syndrome. A newly recognized hereditary disorder of multiple congenital defects, including sudanophilic leukodystrophy, cirrhosis of the liver, and polycystic kidneys. J Pediatr. 1967 Nov;71(5):691–702. doi: 10.1016/s0022-3476(67)80205-1. [DOI] [PubMed] [Google Scholar]
  29. Ring-Larsen H. Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function. Scand J Clin Lab Invest. 1977 Nov;37(7):635–642. doi: 10.3109/00365517709100657. [DOI] [PubMed] [Google Scholar]
  30. Rodes J., Bruguera M., Teres J., Bordás J. M. La insuficiencia renal functional terminal (I.R.F.T.) de la cirrósis hepática con ascitsi. Rev Clin Esp. 1970 Jun 15;117(5):475–482. [PubMed] [Google Scholar]
  31. SHEAR L., KLEINERMAN J., GABUZDA G. J. RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS. Am J Med. 1965 Aug;39:184–198. doi: 10.1016/0002-9343(65)90041-0. [DOI] [PubMed] [Google Scholar]
  32. Shear L., Bonkowsky H. L., Gabuzda G. J. Renal tubular acidosis in cirrhosis. A determinant of susceptibility to recurrent hepatic precoma. N Engl J Med. 1969 Jan 2;280(1):1–7. doi: 10.1056/NEJM196901022800101. [DOI] [PubMed] [Google Scholar]
  33. Shear L., Ching S., Gabuzda G. J. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med. 1970 Jun 18;282(25):1391–1396. doi: 10.1056/NEJM197006182822502. [DOI] [PubMed] [Google Scholar]
  34. Tsantoulas D. C., McFarlane I. G., Portmann B., Eddleston A. L., Williams R. Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis. Br Med J. 1974 Nov 30;4(5943):491–494. doi: 10.1136/bmj.4.5943.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wernze H., Spech H. J., Müller G. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Klin Wochenschr. 1978 Apr 15;56(8):389–397. doi: 10.1007/BF01477293. [DOI] [PubMed] [Google Scholar]
  36. Wilkinson S. P., Arroyo V., Gazzard B. G., Moodie H., Williams R. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet. 1974 Mar 30;1(7857):521–524. doi: 10.1016/s0140-6736(74)92711-1. [DOI] [PubMed] [Google Scholar]
  37. Wilkinson S. P., Bernardi M., Smith I. K., Jowett T. P., Slater J. D., Williams R. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites. Gastroenterology. 1977 Oct;73(4 Pt 1):659–663. [PubMed] [Google Scholar]
  38. Wilkinson S. P., Davies M. H., Portmann B., Williams R. Renal failure in otherwise uncomplicated acute viral hepatitis. Br Med J. 1978 Jul 29;2(6133):338–341. doi: 10.1136/bmj.2.6133.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wilkinson S. P., Hirst D., Day D. W., Williams R. Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure. J Clin Pathol. 1978 Feb;31(2):101–107. doi: 10.1136/jcp.31.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wilkinson S. P., Jowett T. P., Slater J. D., Arroyo V., Moodie H., Williams R. Renal sodium retention in cirrhosis: relation to aldosterone and nephron site. Clin Sci (Lond) 1979 Feb;56(2):169–177. doi: 10.1042/cs0560169. [DOI] [PubMed] [Google Scholar]
  41. Wilkinson S. P., Moodie H., Stamatakis J. D., Kakkar V. V., Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J. 1976 Dec 11;2(6049):1415–1418. doi: 10.1136/bmj.2.6049.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wilkinson S. P., Smith I. K., Clarke M., Arroyo V., Richardson J., Moodie H., Williams R. Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity, and sodium and water excretion. Clin Sci Mol Med. 1977 May;52(5):469–475. doi: 10.1042/cs0520469. [DOI] [PubMed] [Google Scholar]
  43. Wilkinson S. P., Wheeler P. G., Bernardi M., Smith I. K., Williams R. Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of beta-adrenergic blockade. Postgrad Med J. 1979 Dec;55(654):862–867. doi: 10.1136/pgmj.55.650.862. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES